Copyright: ©Author(s) 2026.
World J Orthop. May 18, 2026; 17(5): 116723
Published online May 18, 2026. doi: 10.5312/wjo.v17.i5.116723
Published online May 18, 2026. doi: 10.5312/wjo.v17.i5.116723
Table 1 Summary of included studies on vitamin C in musculoskeletal disorders
| Ref. | Country | Type | Sample size | Condition/population | Dose/route | Duration | Key outcomes |
| Zollinger et al[32], 1999 | Netherlands | RCT | 123 adults (127 fractures) | Conservatively treated wrist fractures | 500 mg oral daily | 50 days | ↓RSD incidence (7% vs 22%) |
| Zollinger et al[33], 2007 | Netherlands | RCT | 416 | Distal radius fractures | 200 mg/500 mg/1500 mg oral | 50 days | ↓CRPS incidence |
| Besse et al[34], 2009 | France | Prospective trial | 329 | Foot & ankle surgery | 1 g oral | 40 days | ↓CRPS-I incidence |
| Shibuya et al[35], 2013 | United States | Systematic review | Pooled | Extremity trauma/surgery | High-dose oral/intravenous injection | Variable | Supportive evidence |
| Evaniew et al[36], 2015 | Canada | Meta-analysis | Pooled | Distal radius fractures | 500 mg oral (pooled) | 45-50 days | Mixed results |
| Aïm et al[37], 2017 | France | Systematic review | Multiple | Wrist fractures | 500 mg oral | 45-50 days | ↓CRPS risk |
| DePhillipo et al[38], 2018 | United States | Systematic review | Multiple | Tendon/bone healing | Vitamin C | Variable | Collagen synthesis support |
| Giustra et al[39], 2021 | Italy | Systematic review | Multiple | Orthopedic CRPS prevention | 500-1000 mg oral | 40-50 days | Possible CRPS benefit |
| Jacques et al[40], 2021 | France | Prospective RCT | 292 (153 intervention/139 control) | Patients undergoing TKA | 1 g/day PO vitamin C | Approximately 40 days post-operative | ↓CRPS-I risk: 3.9% vs 12.2%, OR approximately of 0.27; significant prevention effect |
| Hung et al[26], 2021 | Taiwan (multi-center data pooled) | Meta-analysis of RCTs | Pooled (several hundred across included RCTs) | Orthopedic patients after trauma/surgery (fractures, arthroplasty, etc.) | Oral vitamin C, 500-1000 mg/day (varied by trial) | Up to 1 year (follow-up in included RCTs) | ↓CRPS incidence, improved functional outcomes, some benefit on pain control; overall evidence supportive but heterogeneous |
| Barrios-Garay et al[41], 2022 | Mexico | Systematic review | Multiple | Bone healing | Oral vitamin C | Weeks-months | Mixed healing evidence |
| Çelik et al[42], 2021 | Turkey | Experimental | Animal | Tendon repair | Vitamin C + fibrin clot | Experimental period | Improved tendon healing |
| Noriega-González et al[43], 2022 | Spain | Scoping review | Multiple | Tendinopathy | Vitamin C | Variable | Potential benefit |
| Qamar et al[44], 2024 | United States | Narrative review | Orthopedics | Vitamin C (oral/intravenous injection) | Variable | Proposed uses | |
| Zhang et al[45], 2024 | China/United States | Cohort | NHANES dataset | OA/BMD | Dietary vitamin C | Cross-sectional | Associations with OA risk |
| Chaganti et al[46], 2014 | United States | Cohort | Large cohort | Knee OA | Plasma vitamin C | Years | ↑Vitamin C slowed OA progression |
| Seth et al[27], 2022 | Multiple countries | Systematic review and meta-analysis | 8 studies included | Distal radius, wrist, foot, and ankle fractures | 500 mg or 1000 mg oral | 42-50 days post-injury/surgery | ↓CRPS-I incidence (OR = 0.33, 95%CI: 0.17-0.63) |
| Hosseini-Monfared et al[47], 2025 | Iran | Clinical study | Small | Post-TKA | IV vitamin C | Perioperative | ↓Inflammation, ↓blood loss |
| Azevedo Filho et al[48], 2025 | Brazil | RCT | 122 | Distal radius fractures | 1 g oral | 60 days | ↓Incidence of CRPS at 12 weeks and 24 weeks compared to placebo (P = 0.014 and P = 0.007) |
| Bechara et al[49], 2022 | Australia | Systematic review | Multiple | Various tissue injuries including musculoskeletal tissues | Vitamin C (oral/supplementation) | Variable | ↑Collagen synthesis, ↓oxidative stress, supports tissue repair and regeneration |
| Santos de Lima et al[8], 2023 | Brazil | Meta-analysis | 400 pooled | Exercise-induced damage | Vitamin C + vitamin E | 4-8 weeks | ↓Inflammation, ↓soreness |
| Ramón et al[11], 2023 | Spain | RCT | 80-110 | Post TKA | IV vitamin C | Immediate postop | ↓Inflammation |
| Han et al[50], 2024 | China | Prospective trial | 107 | Total hip arthroplasty patients | IV vitamin C | Perioperative/postoperative | ↑Pain relief, ↑functional recovery, ↓opioid consumption |
| Ueda et al[51], 2025 | Japan | Experimental | In vitro | Tendon cells exposed to oxidative stress | High-dose vitamin C | Variable | ↑Type I collagen gene expression; ↓oxidative stress; maintained cytoskeletal |
| Marzagalli et al[52], 2024 | Italy | Experimental | In vitro | Tenocytes exposed to inflammatory stimuli | Vitamin C + collagen + resveratrol + astaxanthin | Variable | ↓Pro-inflammatory markers; ↑antioxidant capacity; ↓fibrotic response |
| Lassig et al[53], 2023 | United States | RCT | 60 | Mandibular fracture patients | 500 mg oral daily | 6 weeks | ↓Post-operative complications; ↑bone healing biomarkers; ↓wound infection rates |
| Beytemur et al[18], 2024 | Turkey | Experimental | 30 | Steroid-induced ON | Vitamin C + vitamin E | 8 weeks | ↓ON risk |
| Ranjbari and Alimohammadi[19], 2024 | China | Clinical study | 110 | Post-op spinal pain | 1000 mg/day | 4 weeks | ↓Pain |
| Daoust et al[1], 2024 | Canada | Pilot RCT | 160 | Acute MSK injuries (ED) | 1000 mg oral | 14 days | ↓Opioid use, ↓pain |
| He et al[54], 2024 | China | Observational study | 99 postmenopausal women | Postmenopausal osteoporosis | Not applicable (observational study) | Cross-sectional analysis | Combined vitamin C and vitamin D deficiency significantly associated with lower lumbar BMD and higher risk of osteoporosis |
- Citation: Jeyaraman M, Jeyaraman N, Roy M, Nallakumarasamy A, Sami A, Muthu S, Iyengar KP, Jain VK. Systematic review and meta-analysis on vitamin C in musculoskeletal disorders. World J Orthop 2026; 17(5): 116723
- URL: https://www.wjgnet.com/2218-5836/full/v17/i5/116723.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i5.116723